Park Avenue Securities’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.8M Buy
88,935
+66,269
+292% +$3.6M 0.02% 457
2026
Q1
$1.42M Buy
22,666
+2,530
+13% +$202K 0.01% 675
2025
Q4
$1.92M Sell
20,136
-31,595
-61% -$3.1M 0.02% 565
2025
Q3
$5.05M Buy
51,731
+2,150
+4% +$223K 0.04% 324
2025
Q2
$5.33M Buy
49,581
+3,499
+8% +$354K 0.05% 267
2025
Q1
$4.65M Buy
46,082
+33,213
+258% +$3.34M 0.06% 215
2024
Q4
$1.15M Buy
12,869
+1,381
+12% +$122K 0.01% 689
2024
Q3
$963K Sell
11,488
-136
-1% -$10.7K 0.01% 706
2024
Q2
$895K Sell
11,624
-811
-7% -$59.4K 0.01% 716
2024
Q1
$852K Buy
12,435
+1,413
+13% +$90.9K 0.01% 737
2023
Q4
$637K Buy
11,022
+380
+4% +$20.3K 0.01% 811
2023
Q3
$562K Buy
+10,642
New +$558K 0.01% 794
2023
Q1
Sell
-8,515
Closed -$394K 757
2022
Q4
$394K Buy
8,515
+2,454
+40% +$106K 0.01% 868
2022
Q3
$235K Sell
6,061
-697
-10% -$28K ﹤0.01% 1007
2022
Q2
$252K Buy
6,758
+1,933
+40% +$78.7K ﹤0.01% 985
2022
Q1
$214K Buy
+4,825
New +$209K ﹤0.01% 1067
2021
Q4
Sell
-4,629
Closed -$201K 1103
2021
Q3
$201K Buy
+4,629
New +$205K ﹤0.01% 1000
2020
Q4
Sell
-10,603
Closed -$405K 846
2020
Q3
$405K Buy
10,603
+3,354
+46% +$129K 0.01% 480
2020
Q2
$255K Buy
+7,249
New +$261K 0.01% 561
2020
Q1
Sell
-4,732
Closed -$214K 331
2019
Q4
$214K Buy
+4,732
New +$198K 0.01% 558

Other funds holding BSX

Park Avenue Securities's BSX Position: Q2 2026 in Review

Park Avenue Securities increased its Boston Scientific (BSX) stake by 292% in Q2 2026, buying an estimated $3.6M and bringing the position to 88,935 shares worth $3.8M. The position accounts for 0.02% of the portfolio, ranked #457.

Park Avenue Securities first reported a position in BSX in Q4 2019 and has held it in 20 quarters since. The position peaked at $5.33M in Q2 2025. 338 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Park Avenue Securities held 88,935 shares of Boston Scientific worth $3.8M as of Q2 2026.
  • Park Avenue Securities bought 66,269 Boston Scientific shares in Q2 2026, an estimated $3.6M.
  • Boston Scientific made up 0.02% of Park Avenue Securities's portfolio in Q2 2026, its #457 holding.
  • Park Avenue Securities first reported a position in Boston Scientific in Q4 2019 and has held it in 20 quarters since.
  • Park Avenue Securities's Boston Scientific position peaked at $5.33M in Q2 2025.
  • 338 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.